Kristi Reynolds to Heart Failure
This is a "connection" page, showing publications Kristi Reynolds has written about Heart Failure.
Connection Strength
3.032
-
Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction. Am Heart J. 2024 Dec; 278:117-126.
Score: 0.655
-
Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2022 Apr 05; 11(7):e023766.
Score: 0.552
-
Reply: To PMID 26361825. Am J Cardiol. 2015 Nov 01; 116(9):1486.
Score: 0.350
-
Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality. Am J Cardiol. 2015 Aug 01; 116(3):400-5.
Score: 0.343
-
Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
Score: 0.143
-
Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions. JAMA Netw Open. 2022 04 01; 5(4):e228031.
Score: 0.138
-
Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
Score: 0.134
-
Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
Score: 0.125
-
A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
Score: 0.120
-
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
Score: 0.102
-
Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
Score: 0.095
-
Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction. Am J Cardiol. 2015 Oct 01; 116(7):1088-92.
Score: 0.087
-
Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail. 2014 Jan; 7(1):21-7.
Score: 0.078
-
Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins. JAMA Netw Open. 2020 01 03; 3(1):e1918554.
Score: 0.030
-
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
Score: 0.022
-
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32.
Score: 0.021
-
Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015 May; 38(5):905-12.
Score: 0.021
-
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011 Mar 02; 305(9):913-22.
Score: 0.016